Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: My forecast

The financials will reflect this anticipated development. Overall I'm expecting $ 0.15 - $ 0.19 EPS until the end of May 2008 (fiscal year end PTSC).

As I've stated here many times before I'm anticipating a settlement range between $ 110 M - $ 180 M. I'm expecting the revenues for PDS delivered until now in this quarter from the 4 existing signings including Royal Philips to be around $ 20M

 

 

Would that not indicate an upper target of $0.25?

 

Be well

 

 

 

Share
New Message
Please login to post a reply